Literature DB >> 15851086

Adult acute disseminated encephalomyelitis associated with poststreptococcal infection.

M M Ning1, S Smirnakis, K L Furie, V L Sheen.   

Abstract

Acute disseminated encephalomyelitis (ADEM) is a monophasic illness that is thought to develop from antigenic mimicry with antibodies having cross-reactivity to host epitopes in the nervous system. The disorder typically follows an exanthematous or recent viral infection. In contrast, complications from bacterial poststreptococcal infections more commonly give rise to disorders in the pediatric population including Sydenham's chorea, pediatric autoimmune neuropsychiatric disorders, and ADEM. We present the novel case of documented streptococcal pharyngitis and elevated antideoxyribonuclease B (ADNB) titers in an adult giving rise to ADEM. Furthermore, the absence of basal ganglia abnormalities on MRI and the degree of leukocytosis in the CSF distinguish the adult form of ADEM from childhood ADEM and adult viral demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851086     DOI: 10.1016/j.jocn.2004.03.030

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.

Authors:  Thomas Williams; John Thorpe
Journal:  J Med Case Rep       Date:  2012-09-19

2.  Parainfectious encephalomyeloradiculitis associated with bacterial meningitis: a case report.

Authors:  Yuji Kato; Takeshi Hayashi; Akira Uchino; Ichiro Deguchi; Norio Tanahashi
Journal:  J Med Case Rep       Date:  2015-02-10

Review 3.  The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.

Authors:  Samantha E Marin; David J A Callen
Journal:  Neuroimaging Clin N Am       Date:  2013-02-26       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.